The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders

Annals of Hematology

Volumn 72, Issue 4, 1996, Pages 184-193

  Licht, T ^a   Pastan, I ^b   Gottesman, M M ^b   Herrmann, F ^a  

^a UNIVERSITY OF ULM   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Dihydrofolate reductase; Hematopoietic stem cells; Myelosuppression; P glycoprotein

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; AZIDOPINE; CALCIUM CHANNEL BLOCKING AGENT; COMPLEMENTARY DNA; DACTINOMYCIN; DIHYDROFOLATE REDUCTASE; DOCETAXEL; EPIPODOPHYLLOTOXIN; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; NEUROLEPTIC AGENT; NIFEDIPINE; NIGULDIPINE; PACLITAXEL; STEROID HORMONE; STEROID HORMONE ANTAGONIST; VERAPAMIL; VINCA ALKALOID;

BONE MARROW; BONE MARROW SUPPRESSION; CANCER; CANCER CHEMOTHERAPY; CELL PROTECTION; DRUG TRANSPORT; EXPRESSION VECTOR; GENE EXPRESSION; GENE STRUCTURE; GENE THERAPY; GENE TRANSFER; GENETIC SELECTION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; MARKER GENE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RETROVIRUS; REVIEW; TRANSGENIC ANIMAL;

GENE THERAPY; HEMATOLOGIC DISEASES; HUMANS; NEOPLASMS; P-GLYCOPROTEIN;

EID: 0029926220     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050159     Document Type: Review

References (118)

1. Altuvia S, Stein WD, Goldenberg S, Kane SE, Pastan I, Gouesman MM (1993) Targeted disruption of the mouse mdr1b reveals that steroid hormones enhance mdr gene expression. J Biol Chem 268:27127-27132
2. Arnbudkar SV, Lelong IH, Zhang JP, Cardarelli CO, Gouesman MM, Pastan I (1992) Partial purification and reconstitution of the human multidrug-resistance pump - characterization of drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci USA 89:8472-8476
3. Ambudkar SV, Pastan I, Gottesman MM (1995) Cellular and biochemical aspects of multidrug resistance. In: Georgopapadakou NH (ed) Drug transport in antimicrobial and anticancer chemotherapy. Marcel Dekker, New York
4. Ames GF-L, Lecar H (1992) ATP-dependent bacterial transporters and cystic fibrosis: analogy between channels and transporters. FASEB J 6: 2660-2666
5. Aran JM, Gottesman MM, Pastan I (1994) Drug-selected coexpression of human glucocerebrosidase and P-glycoprotem using a bicistronic vector. Proc Natl Acad Sci USA 91:3176-3180
6. Aran JM, Licht T, Gottesman MM, Pastan M (1995) Design of a multidrug-resistance - marking vector. Proc Am Assoc Cancer Res 36:336
7. Beck WT (1989) Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance. J Natl Cancer Inst 81:1683-1684
8. Bertolini F, de Monte L, Corsini C, Lazzari L, Lauri E, Soligo D, Ward M, Bank A, Malvasi F (1994) Retrovirus-mediated transfer of the multidrug-resistance gene into human haematopoietic progenitor cells. Br J Haematol 88:318-324
9. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW (1991) Survival and retrovirus infection of marine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp Hematol 19:206-212
10. Bodine DM, Moritz T, Donahue RE, Luskev BD, Kessler SW, Martin DI, Orkin SH, Nienhuis AW (1993) Long-term in vivo expression of a marine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. Blood 82:1975-1980
11. Bodine DM, Seidel NE, Gale MS, Nienhuis. AW, Orlic D (1994) Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colont-stimulating factor and stem cell factor. Blood 84:1482-1491
12. Boesch, D. Gaveriaux, C. Jachez B, Pourtier-Manzanedo A, Bollinger P. Loor F (1991) In vivo circumvention of P-glycoprotein-mediated multi-drug resistance of tumor cells with SDZ PSC833. Cancer Res 51:4226-4233
13. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L (1995) Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283-287
14. Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM (1995) Differential effects of P-glycoprotein inhibitors on NIH 3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res 55:1086-1091
15. Carr F, Medina WD, Dube S, Bertino JR (1983) Genetic transformation of murine bone marrow cells to methotrexate resistance. Blood 62:180-185
16. Carulli G, Petrini M (1990) Muitidrug resistance: focus in hematology. Haematologica (Pavia) 75:363-374
17. Chaudhary PM, Roninson IB (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-94
18. Chaudhary PM, Mechetner EB, Roninson IB (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2729-2734
19. Clarke DM, Loo TW (1993) Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. J Biol Chem 268:3143-3149
20. Cline MJ, Stang H, Mercola K, Morse L, Ruprecht R, Browne J. Salse W (1980) Gene transfer in intact animals. Nature 284:422-425
21. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654
22. Cordon-Cardo C, O'Brian JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Muitidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698
23. Corey CA, DeSilva AD, Holland CA, Williams DA (1990) Serial transplantation of methotrexate resistant bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood 76:337-343
24. Corrias MV, Tonini GP (1992) An oligomer complementary to the 5' end region of the MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma multidrug-resistant cells. Anticancer Res 12:1431-1438
25. Cournoyer D, Létourneau S, Greenbaum M (1995) Hematopoietic chemoprotection from alkylating drugs by glutathione-S-transferase gene transfer. Blood 86:243A
26. Daniel V (1993) Glutathione S-transferases: gene structures and resulation of expression. Crit Rev Biochem Mol Biol 28:173-270
27. Deisseroth AB, Kavanagh J, Champlin R (1994) Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial. Hum Gene Ther 5:1507-1522
28. DelaFlor-Weiss E, Richardson C, Ward M, Himelstein A, Smith L, Podda S, Gottesman M, Pastan I, Bank A (1992) Transfer and expression of the human multidrug-resistance gene in mouse erythroleukemia cells. Blood 80:3106-3111
29. D'Hondt V, Caruso M, Ward M, Cole S, Deeley R, Bank A (1995) Expression of the multidrug-resistance gene using retroviral vectors. Blood 86:466A
30. RIII. J Biol Chem 265:8317-8321
31. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M (1992) Subpopulations of normal and peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80:2735-2739
32. Dunbar CE, Bodine DM, Sorrentino B, Donahue R, McDonagh K. Cottler-Fox M. O'Shaughnessy JA (1994) Gene transfer into hematopoietic cells: implications for cancer therapy. Ann NY Acad Sci 716:216-224
33. Efferth T, Volm M (1993) Modulation of P-glycoprotein mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells. Oncology 50:303-308
34. Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137-171
35. Fleming GF, Amato JM, Agresti M, Safa AR (1992) Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein. Cancer Chemother Pharmacol 29:445-449
36. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 86:695-698
37. Ford JM, Hait WN (1993) Pharmacologic circumvention of multidrug resistance. Cytotechnology 12:171-212
38. Ford JM, Prozialeck WC, Hait WN (1989) Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance in human and murine cell lines. Mol Pharmacol 35:105-115
39. Ford JM, Bruggemann EP, Pastan I, Gottesman MM, Hait WN (1990) Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. Cancer Res 50:1748-1756
40. Galski H, Sullivan M, Willingham MC, Chin K-V, Gottesman MM, Pastan I, Merlino GT (1989) Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin induced leukopenia. Mol Cell Biol 9:4357-4363
41. Germann UA (1993) Molecular analysis of the multidrug transporter. Cytotechnology 12:33-62
42. Germann UA, Chin K-V, Pastan I. Gottesman MM (1990) Retroviral transfer of a chimeric multidrug resistance-adenosine deaminase gene. FASEB J 4:1501-1507
43. Germann UA, Pastan I, Gottesman MM (1993) P-glycoproteins: mediators of multidrug resistance. Semin Cell Biol 4:63-76
44. Gianni AM, Bregni M, Sena S, Orazi A, Stern AC, Gandola L. Bonnadonna B (1990) Recombinant human granulocyte macrophage stimulating factor reduces hematologic toxicity and widens clinical applicability of cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 8:768-778
45. Goldstein L, Galski H, Fojo A, Willingham M, Lai S-I, Gadzar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M. Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug-resistance gene in human cancers. J Natl Cancer Inst 81:116-124
46. Gottesman MM, Pastan I (1991) The multidrug resistance (MDR1) gene as a selectable marker in gene therapy. In: Cohen-Haguenauer O, Boiron M (eds) Human gene transfer, vol 219. Coloque INSERM/John Libbey Eurotext, London, pp 185-191
47. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated bv the multidrug transporter. Annu Rev Biochem 62:385-427
48. Gottesman MM, Germann UA, Aksentijevich I, Sugimoto Y, Cardarelli CO, Pastan I (1994) Gene transfer of drug-resistance genes. Ann NY Acad Sci 716:126-139
49. Gottesman MM. Hrycyna CA, Schoenlein PV, Germann UA, Pastan I (1995) Genetic analysis of the multidrug transporter. Annu Rev Genet (in press)
50. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357-361
51. Gros P, Dhir R, Croop J, Talbot F (1991) A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drua efflux pumps. Proc Natl Acad Sci USA 88:7289-7293
52. Haber DA, Beverly SM, Kiely ML, Schminke RT (1981) Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J Biol Chem 256:9501-9510
53. Hanania EG, Deisseroth AB (1994) Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther 1:21-25
54. Herrmann F, Brugger W, Kanz L, Mertelsmann R (1992) In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells. Semin Oncol 19:422-431
55. Hesdorffer C, Antman K, Bank A, Fetell M, Mears G, Begg M (1994) Human MDR1 gene transfer in patients with advanced cancer. Hum Gene Therapy 5:1151-1160
56. Higgins CF (1993) The ABC transporter channel superfamily - an overview. Semin Cell Biol 4:1-5
57. Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, Gullagher MP, Gill DR, Hubbart RE, Higgins CF (1990) Structural and functional relationships of ATP-binding proteins associated with cystic fibrosis. multidrug resistance and bacterial transport. Nature 346:362-365
58. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta 455:152-162
59. Karlsson S (1991) Treatment of genetic defects in hematoporetic cell function by gene transfer. J Natl Cancer Inst 78:2481-2492
60. Kaye SB, Kerr DJ (1991) Multidrug resistance: clinical relevance in haematological malignancies. Blood Rev 5:38-41
61. Kiehntopf K, Brach MA, Licht T, Petschauer S, Karawajew L, Kirschning C, Herrmann F (1994) Ribozyme mediated cleavage of MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J 13:4645-4652
62. Klimecki WT, Futscher BW, Grogan TM, Dalton WS (1994) P-glvcoprotein expression and function in circulating blood cells from normal volunteer. Blood 83:2451-2458
63. Kobayashi H, Dorai T, Holland JF, Ohnuma T (1993) Cleavage of human MDR1 by a hammerhead ribozyme. FEBS Lett 319:71-74
64. Kruh GD, Chan A, Myers K, Gaughan K, Miki T, Aaronson SA (1994) Expression complementary DNA library transfer establishes mrp is a multidrug-resistance gene. Cancer Res 54:1649-1652
65. Laver J, Moore MAS (1989) Clinical use of recombinant human growth factors. J Natl Cancer Inst 81:1370-1382
66. Li M-X. Banarjee D, Zhao S-C, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR (1994) Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood 83:3403-3408
67. Licht T, Pastan I, Gottesman MM, Herrmann F (1994) P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. Ann Hematol 69:159-171
68. Licht T, Aksentijevich I, Gottesman MM, Pastan I (1995) Efficient expression of functional human MDR1 gene in murine bone marrow after retroviral transduction of purified hematopoietic stem cells. Blood 86:111-121
69. Licht T, Aran JM, Goldenberg SK, Vieira WD, Gottesman MM, Pastan I (1995) Cytotoxic drug selection of murine bone marrow cells following transfer of the MDR1 (multidrug resistance) gene increases gene expression and chemoresistance in vivo. Blood 86:243A
70. Lincke CR, Smit JJM, van der Velde-Koerts T, Borst P (1991) Structure of the human MDR3 gene and physical mapping of the MDR locus. J Biol Chem 266:5303-5310
71. List AF, Spier CM (1992) Multidrug resistance in acute leukemia: a conserved physiologic function. Leuk Lymphoma 8:9-14
72. Lum BL, Fisher GA, Brophy NA, Yahanda AM, Adler KM, Kaubisch S, Halsey J, Sikic BI (1993) Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations. Cancer 72:[Suppl 11]3502-3514
73. Mclvor RS, Simonsen CC (1990) Isolation and characterization of a variant dihydrofolate reductase cDNA from the methotrexate resistant murine L5178Y cells. Nucleic Acids Res 18:7025-7032
74. McLachlin JR, Eglitis MA, Ueda K, Kantoff PW, Pastan I, Anderson WF, Gottesman MM (1990) Expression of a human complementary DNA for the human mullidrug-resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J Natl Cancer Inst 82:1260-1263
75. Marie JP, Brophy NA, Ehsan MN, Aihara Y, Mohamed NA, Cornbleet J, Chao NJ, Sikic BI (1992) Expression of multidrug-resistance gene mdr1 mRNA in a subset of normal bone marrow cells. Br J Haematol 81:145-152
76. Mickisch GH, Licht T, Merlino GT, Gottesman MM, Pastan I (1991) Chemotherapy and chemosensitization of transgenic mice which express the human multidrug-resistance gene in bone marrow: efficacy, potency and toxicity. Cancer Res 51:5417-5424
77. Mickisch GH, Merlino GT, Galski H, Gottesman MM, Pastan I (1991) Transgenic mice which express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents which reverse drug resistance. Proc Natl Acad Sci USA 88:547-551
78. Mickisch GH, Aksentijevich I, Schoenlein PV, Goldstein LJ, Galski H, Staehle C, Sachs DH, Pastan I, Gottesman MM (1992) Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice. Blood 79:1087-1093
79. Mickisch GH, Pai LH, Siegsmund M, Campain J, Gottesman MM. Pastan I (1993) Pseudomonas exotoxin conjugated to monoclonal antibody MRK16 specifically kills multidrug-resistant cells in cultured renal cell carcinomas and in MDR-transgenic mice. J Urol 149:174-178
80. Miller AD (1990) Progress towards human gene therapy. Blood 76:271-278
81. Miller AD, Law M-F. Verma IM (1985) Generation of a helper free amphotropic retrovirus that transduces a dominant acting methotrexate resistant dihydrofolate reductase gene. Mol Cell Biol 5:431-437
82. Neidhart JA (1993) Hematopoietic cytokines. Current use in cancer therapy. Cancer 72:[Suppl 11]3381-3386
83. Neyfakh AA, Serpinskaya AS, Chervonsky AV, Apasov SG, Kazarov AR (1989) Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp Cell Res 185:496-505
84. Ogawa M (1993) Differentiation and proliferation of stem cells. Blood 81:2844-2853
85. O'Shaughnessy JA, Cowan KH, Nienhuis AW, McDonagh KT, Sorrentino BP, Dunbar CE, Chiang Y, Wilson W, Goldspiel B, Kohler D, Cottler-Fox M, Leitman SF, Gottesman MM. Pastan I, Denicoff A. Noone M, Gress R (1994) Retroviral mediated transfer of the human multidrug-resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Hum Gene Ther 5:891-911
86. Padmanabhan R, Padmanabhan R, Howard T, Gottesman MM, Howard BH (1993) Magnetic affinity cell sorting to isolate transiently transfected cells, multidrug-resistant cells, somatic cell hybrids, and virally infected cells. Methods Enzymol 218:637-651
87. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85:4486-4490
88. Pearson JW, Fogler WE, Volker K, Usui N, Goldenberg SK, Gruys E, Riggs CW, Komschlies K, Wiltrout RH, Tsuruo T, Pastan I, Gottesman MM, Longo DL (1991) Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody. J Natl Cancer Inst 83:1386-1391
89. Podda S, Ward M, Himelstein A, Richardson C, de la FlorWeiss E, Smith L, Gottesman MM, Pastan I. Bank A (1992) Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89:9676-9680
90. Rao US, Fine RL, Scarborough GA (1994) Antiestrogens and steroid hormones: substrates of human P-glycoprotein. Biochem Pharmacol 48:287-292
91. Richardson C, Ward M, Podda S, Bank A (1994) Mouse fetal liver cells lack amphotropic retroviral receptors. Blood 84:433-439
92. Safa AR, Stern RK, Choi K, Agresti M, Tamai I, Mehta ND, Roninson IB (1990) Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185 - Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA 87:7225-7229
93. Scanlon KJ, Ishida H, Kashani-Sabet M (1994) Ribozymemediated reversal of the multidrug-resistant phenotype. Proc Natl Acad Sci USA 91:11123-11127
94. Schinkel AH, Roelofs MEM, Borst P (1991) Characterization of human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res 51:2628-2635
95. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P (1994) Disruption of the mouse mdrla leads to a deficiency in the blood-brain barrier and to increased sensitivitv to drugs. Cell 77:491-502
96. Schoenlein PV, Shen DW, Barrett JT, Pastan I, Gottesman MM (1992) Double minute chromosomes carrying the human multidrug resistance 1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicine-selected KB cells. Mol Biol Cell 3:507-520
97. Shen D-w, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM (1986) Human multidrug resistant cell lines: increased mdr1 gene expression can precede gene amplification. Science 232:643-645
98. Simonsen CC, Levinson AD (1983) Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc. Natl Acad Sci USA 80:2495-2499
99. Smit JJ, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Dccmter L, Mol CAAM, Ottenhoff R, van der Lugt NMT, van Room MA, van der Valk MA, Offerhaus GJA Berns AJM, Borst P (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451-462
100. Sonneveld P, Durie BDM, Lokhorst HM, Marie JP, Solbu G, Suciu S, Zittoun R, Lowenberg B, Nooter K for the Leukemia Group of the EORTC and the HOVON (1992) Modulation of multidrug-resistant multiple myeloma by cyclosporine. Lancet 340:255-259
101. Sorrentino BP, Brandt SJ, Bodine D, Gottesman MM, Pastan I. Cline A, Nienhuis AW (1992) Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99-103
102. Srimatkandada S, Schweitzer BI, Moroson BA, Dube S, Bertino JR (1989) Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with a decreased binding to MTX in a human colon carcinoma cell line, HCT-8R4 resistant to this drug. J Biol Chem 264:3524-3528
103. Stein WD, Cardarelli C, Pastan I, Gottesman MM (1994) Kinetic evidence suggesting that the multidrug transporter differentially handles influx of its substrates. Mol Pharmacol 45:763-772
104. Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, Mori S (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16, Cancer Res 48:1926-1929
105. Sugimoto Y, Aksentijevich I, Gottesman MM, Pastan I (1994) Efficient expression of drug-selectable genes under control of an internal ribosome entry site. Biotechnology 12:694-698
106. Sugimoto Y. Aksentijevich I, Murray G, Brady RO, Pastan I, Gottesman MM (1995) Retroviral co-expression of a multidrug-resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease. Hum Gene Ther 6:905-915
107. Sugimoto Y, Hrycyna CA, Aksentijevich I, Pastan I, Gottesman MM (1995) Co-expression of a multidrug-resistance gene (MDR1) and herpes simplex virus thymidine kinase gene as a part of a bicistronic mRNA in a retrovirus vector allows selective killing of MDR1-transduced cells. Clin Cancer Res 2:447-457
108. Szilvassy SJ, Cory S (1993) Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. Blood 81:2310-2320
109. Tang-Wai DF, Kajaji S, DiCapua F, de Graaf D, Roninson IB, Gros P (1995) Human (MDR1) and mouse (mdrl. mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry 34:32-39
110. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product in normal human tissues. Proc Natl Acad Sci USA 84, 7735-7738
111. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1989) Immunocytochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J Histochem Cytochem 37:159-164
112. Tsuruo T, Iida K, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 43:808-813
113. Tsuruo T, Hamada H, Sato S, Heike Y (1989) Inhibition of multidrug-resistant human tumor cell growth in athymic mice by anti-P-glycoprotein monoclonal antibodies. Jpn J Cancer Res 80:627-631
114. Ueda K, Clark DP, Chen C-J, Roninson IB, Gottesman MM, Pastan I (1987a) The human multidrug-resistance (mdr1) gene:cDNA cloning and transcription initiation. J Biol Chem 262:505-508
115. + cells. Blood 84:1408-1414
116. Williams DA, Hsieh K, DeSilva A, Mulligan RC (1987) Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate resistant bone marrow. J Exp Med 166:210-218
117. Zaman GJR Versantvoort CHM, Smit JJM, Eijedems WHM, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas F, Borst P (1993) Analysis of the expression of MRP. the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53:1747-1750
118. Zhao SC, Li M-X, Banerjee D, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR (1994) Long term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double copy vector retrovirus containing a mutant dihydrofolate reductase. Cancer Gene Ther 1:27-33